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MicroRNAs (miRNAs) are essential regulators of
development, physiology, and evolution, and their
biogenesis is strictly controlled at multiple levels.
Regulatory proteins, such as KSRP, modulate rates
and timing of enzymatic reactions responsible for
maturation of select miRNAs from their primary tran-
scripts in response to specific stimuli. Here, we show
that KSRP silencing in mesenchymal C2C12 cells
produces a change in the transcriptome largely over-
lapping that induced by bone morphogenetic protein
2 (BMP2) signaling activation. This induces osteo-
blastic differentiation while preventing myogenic
differentiation. KSRP silencing- and BMP2-depen-
dent myogenic miRNA (myomiR) maturation block-
ade is required for osteoblastic differentiation of
C2C12 cells. Our results demonstrate that phosphor-
ylated R-SMAD proteins, the transducers of BMP2
signal, associate with phosphorylated KSRP and
block its interaction with primary myomiRs. This
abrogates KSRP-dependent myomiR maturation,
with SMAD4, SMAD5, and SMAD9 silencing being
able to rescue KSRP function. Thus, SMAD-induced
blockade of KSRP-dependent myomiR maturation is
critical for orienting C2C12 cell differentiation toward
osteoblastic lineage.INTRODUCTION
Posttranscriptional regulation of gene expression is a multilay-
ered process used by cells to modulate many fundamental
functions, and in this context, microRNAs (miRNAs) have
emerged as critical regulators (Krol et al., 2010). Reflecting the
broad impact of miRNAs on gene expression, their deregulation
has been demonstrated in a variety of cancers as well as in someCell Reinflammatory, neurodegenerative, and cardiovascular diseases
(Mendell and Olson, 2012).
It is now clear that miRNA maturation from precursors is
dynamically regulated in response to a variety of stimuli (Trabuc-
chi et al., 2009a). Once transcribed, primary miRNAs (pri-miR-
NAs) are cleaved into stem-loop-structured precursor miRNAs
(pre-miRNAs) by Drosha-containing complex. Each pre-miRNA
is exported into the cytoplasm and cleaved by Dicer-containing
complex into a short duplex with one strand being selected and
incorporated into the effector machinery, which determines gene
silencing (Krol et al., 2010).
We and others have reported that the single-strand RNA-
binding protein KH-type splicing regulatory protein (KSRP)
interacts with select miRNA precursors and promotes their
processing (Gherzi et al., 2010). This, in turn, contributes to
convey cell signaling into changes of miRNA maturation (Zhang
et al., 2011; Briata et al., 2012). KSRP displays functional plas-
ticity and can regulate several additional aspects of RNA life
with the decay-promoting function of labile mRNAs being
extensively studied (Gherzi et al., 2010). We recently reported
that a dynamic switch between distinct KSRP functions,
following its phosphorylation by AKT, is essential for matura-
tion of muscle-specific miRNAs (myogenic miRNAs [myomiRs])
and for myogenic differentiation of C2C12 mesenchymal cells
(Briata et al., 2012). KSRP-deficient mice do not display overt
muscular abnormalities, but KSRP absence impairs myomiR
maturation in the course of injury-induced muscle regeneration
even though the effect of KSRP knockout is transient (Briata
et al., 2012). Interestingly, a similar phenotype of delayed
skeletal muscle regeneration in response to injury has
been recently described in miR-206 knockout mice (Liu et al.,
2012).
Bone morphogenetic proteins (BMPs), members of the
transforming growth factor beta (TGF-b)/BMP superfamily,
generate a wide range of biological effects in various cell types
and are potent inducers of osteoblastic differentiation from
mesenchymal progenitors (Rosen, 2009). BMPs bind to specific
transmembrane receptors and, by sequentially inducing
receptor serine kinase activity, cause SMAD protein (SMAD)ports 2, 1159–1168, November 29, 2012 ª2012 The Authors 1159
phosphorylation (Miyazono et al., 2010). The receptor-regulated
SMADs (R-SMADs: SMAD1, SMAD5, and SMAD9) once
phosphorylated and complexed with SMAD4, translocate into
the nucleus where they induce transcription of osteoblastic
determination and differentiation factors (Miyazono et al.,
2010). Recently, Hata and coworkers reported that SMADs
interact with select pri-miRNAs in a sequence-specific manner
and favor their maturation in a smooth muscle cell line (Davis
et al., 2008, 2010).
Mesenchymal cell differentiation is regulated by integrated
signaling networks that orchestrate changes in gene expression
leading to commitment to specific cell lineages (Asakura et al.,
2001). C2C12 cells possess the ability to differentiate into myo-
fibers upon serum withdrawal or into osteoblasts upon addition
of BMP to the culture medium, thus representing a powerful
tool to dissect molecular events underlying cell differentiation
(Katagiri et al., 1994).
In this study, we identified an unanticipated role for the phos-
phorylated-R-SMADs/SMAD4 complex that, interacting with
KSRP, impairs its ability to bind to primary myomiRs and to
promote their processing. These events are required to orient
fate decisions of mesenchymal C2C12 cells determining osteo-
blast differentiation.
RESULTS
KSRP Knockdown in C2C12 Cells Reshapes the
Transcriptome Favoring Osteoblast Differentiation
We investigated the consequences of KSRP knockdown on
gene expression in C2C12 cells that are able to differentiate
either toward myotubes upon serum withdrawal (differentiation
medium, DM) or toward osteoblasts upon addition of BMP2 to
DM (Katagiri et al., 1994). KSRP was stably knocked down
(shKSRP) in undifferentiated C2C12 cells (GM, growth medium;
Figure S1A), and gene expression was analyzed by transcrip-
tome sequencing (RNA-seq). Analysis of data obtained com-
paring mock-transfected and shKSRP cells revealed gene
expression changes reminiscent of those previously described
in cells treated with BMP2 to induce osteoblastic differentiation
(Balint et al., 2003) (Figure 1A, examples of upregulated osteo-
genic markers [top] and downregulated myogenic markers
[bottom]; Table S1). Results have been validated by quantitative
RT-PCR (qRT-PCR) analysis, immunoblotting, and cell staining.
Increased expression of Runx2, a critical regulator of the osteo-
genic lineage, as well as of osteomodulin (Omd), fibromodulin
(Fmod), and collagen 6a2 (Col6a2), was detected in shKSRP
C2C12 cells (Balint et al., 2003) (Figures 1B, 1C, and S1B; data
not shown) and was reproduced by transient KSRP silencing
(siKSRP; Figure S1C). Importantly, alkaline phosphatase (AP)
activity was present in shKSRP C2C12 cells cultured in GM (Fig-
ure 1D; Rattner et al., 2000). Strikingly, systematic bioinformatic
analysis of the global transcriptome changes consequent to
KSRP silencing in C2C12 cells cultured in GM (compared to
mock-transfected cells) showed that 93% of the significantly up-
regulated and 87%of the significantly downregulated transcripts
were concordantly regulated by BMP2 treatment (Figure 1E).
Furthermore, KSRP silencing enhanced the magnitude of the
BMP2-dependent osteoblastic marker induction (Figures S1D1160 Cell Reports 2, 1159–1168, November 29, 2012 ª2012 The Autand S1E, right panels) and abrogated the induction of myogenic
markers upon a myogenic stimulus (DM), inducing the expres-
sion of osteoblastic transcripts and of AP (Figures 1F and S1E,
left panels).
Considering that KSRP is known to promote rapid decay of
unstable mRNAs, we assumed that transcripts whose levels
were downregulated upon KSRP silencing reflected an indirect
modulation through KSRP-regulated factors able to impair
gene expression, and we initially focused on labile transcripts
whose expression was upregulated in KSRP knockdown cells.
Interestingly, we found that the levels of transcripts encoding
members of the BMP/SMAD signaling pathway were upregu-
lated in shKSRP C2C12 cells (Figure 1A; Table S1; data not
shown). BMP-receptor 2 (Bmpr2), Smad5, and Smad9 expres-
sion was significantly increased in KSRP-silenced cells when
compared to mock-silenced cells (Figures 2A, 2B, and S2A).
We found that KSRP interacts with the 30 UTRs of Bmpr2,
Smad5, and Smad9 mRNAs, and its knockdown enhances the
stability of these labile mRNAs (Figures S2B and S2C). Impor-
tantly, as revealed by the induction of phosphorylated SMAD5
and SMAD9, the BMP/SMAD signaling pathway was activated
in KSRP knockdown cells (Figures 2B and S2D). Comparable
results were obtained by silencing KSRP in another mesen-
chymal cell line (C3H/10T1/2, Figure S2E). The relevance of
BMP/SMAD signaling activation occurring in shKSRP C2C12
cells in determining the osteoblastic phenotype in the absence
of any stimuli was underscored by the reduction of Runx2 and
Fmod expression consequent to SMAD5 and SMAD9 knock-
down (Figure 2C). Altogether, our data suggest the implication
of KSRP in the BMP/SMAD signaling pathway, allowing us to
hypothesize that its function is required at the crossroad
between myogenic and osteoblastic differentiation to orient
C2C12 cell fate.
BMP/SMAD Signaling Impairs KSRP Ability to Promote
Primary myomiR Maturation
We observed that KSRP silencing in undifferentiated C2C12
cells induced the expression of proteins that, apart from being
involved in osteoblastic differentiation, are validated targets of
myomiRs (i.e., CONNEXIN 43, also known as GJ1A, and
HDAC4, Figures 1A and S3A; Chen et al., 2006; Inose et al.,
2009). Considering this finding and the essential role of KSRP
in pri-miRNA processing (Ruggiero et al., 2009; Trabucchi
et al., 2009b; Zhang et al., 2011; Briata et al., 2012), we wanted
to explore KSRP-dependent modulation of miRNA maturation in
osteoblast differentiation. We first investigated the expression of
miRNAs that have been previously described to be modulated
during osteoblast differentiation (Kapinas and Delany, 2011)
and observed that most of them are not regulated in C2C12 cells
under our experimental conditions except for miR-26a, miR-
125b-5p, and miR-19b (Figure S3B; data not shown). However,
the expression of miR-26a, miR-125b-5p, and miR-19b was
not affected by KSRP silencing (Figure S3B), and their functional
role was not further explored.
Among miRNAs whose function has been implicated in both
myogenic and osteoblastic differentiation, although with oppo-
site outcome (Inose et al., 2009; Kim et al., 2006; Chen et al.,
2006; Li et al., 2008), we focused on miR-206 and miR-133bhors
Figure 1. KSRP Knockdown in C2C12 Cells Favors Osteoblast Differentiation
(A) Selection of transcripts either upregulated (top) or downregulated (bottom) in stably KSRP-silenced (shKSRP) C2C12 cells (when compared to
mock-transfected [mock] C2C12 cells) derived from a comparison of the results obtained by transcriptome analysis (RNA-seq) with data published in Balint et al.
(2003). Green and red colors in the heatmap indicate a decrease and increase of mRNA levels, respectively.
(B) qRT-PCR analysis of the indicated transcripts in either mock or shKSRP C2C12 cells cultured in GM.
(C) Immunoblot analysis of total-cell extracts from either mock or shKSRP C2C12 cells cultured in GM using the indicated antibodies. The position of molecular
mass markers is indicated on the left. Representative gels are shown.
(D) AP staining of either mock or shKSRP C2C12 cells cultured in GM. A representative staining is displayed.
(E) Bioinformatic analysis of the RNA-seq data. Schematic representation of the overlap between transcripts either upregulated (top) or downregulated (bottom) in
BMP2-treated mock-C2C12 cells and transcripts concordantly regulated in shKSRP C2C12 cells cultured in GM. Transcripts derived from mock-transfected
C2C12 cells cultured in GMwere first compared either with transcripts derived frommock-transfected cells cultured in DM plus BMP2 or with transcripts derived
from shKSRPC2C12 cells cultured in GM.OnlymRNAswhose expression significantly (p < 0.01) differedwere included in further comparisons. Arrowheads point
to the percentage of overlapping transcripts (whose regulation is in common between BMP2-treated mock-transfected C2C12 cells and shKSRP C2C12 cells
cultured in GM).
(F) qRT-PCR analysis of the indicated transcripts in either mock or shKSRP C2C12 cells cultured in DM.
The values of qRT-PCR experiments shown are averages (±SEM) of three independent experiments performed in triplicate. Statistical significance: *p < 0.005,
**p < 0.001 (Student’s t test).
See also Figure S1.(hereafter indicated as myomiRs) that are expressed at relevant
levels also in C2C12 cells cultured in GM (data not shown).
Indeed, KSRP knockdown abrogated the basal maturation ofCell RemiR-206 and miR-133b observed in GM and, similarly to
BMP2 treatment, blocked their DM-induced maturation from
primary transcripts (Figure 3A; Sato et al., 2009). Finally, KSRPports 2, 1159–1168, November 29, 2012 ª2012 The Authors 1161
Figure 2. BMP-SMAD Signaling Activation
Is Implicated in KSRP Knockdown-Depen-
dent Phenotype Changes in C2C12 Cells
(A) qRT-PCR analysis of the indicated transcripts
in either mock or shKSRP C2C12 cells cultured
in GM.
(B) Immunoblot analysis of total-cell extracts from
either mock or shKSRP C2C12 cells cultured in
GM using the indicated antibodies. The two anti-
bodies recognize either total or phosphorylated
SMAD1, SMAD5, and SMAD9, but the expression
of Smad1 mRNA was barely detectable in C2C12
cells (data not shown). The position of molecular
mass markers is indicated on the left. Represen-
tative gels are shown.
(C) qRT-PCR analysis of the indicated transcripts
in KSRP-silenced C2C12 cells transfected with
either control siRNA or siRNAs to SMAD5 and
SMAD9 (as indicated).
The values of qRT-PCR experiments shown are
averages (±SEM) of three independent experi-
ments performed in triplicate. Statistical signifi-
cance: *p < 0.01, **p < 0.001 (Student’s t test).
See also Figure S2.knockdown and BMP2 treatment showed additive effects
completely abrogating myomiR maturation (Figure 3A). The
levels of pre-myomiRs mirrored those of the mature forms indi-
cating that the arrest of maturation induced by BMP2 treatment
and KSRP silencing occurred at the Drosha-processing level
(data not shown). Forced re-expression of myomiRs in KSRP-
silenced cells (Figure S3C) was able to counteract the increased
expression of the components of the BMP/SMAD signaling
pathway (Figure S3D) and caused a reduction of osteoblastic
marker levels, demonstrating the essential role played by the
blockade of myomiR maturation in the phenotype of shKSRP
C2C12 cells, with transfectedmiR-206 also inducing a significant
increase in myogenin expression (Figure S3E).
We hypothesized that the mechanism by which BMP signaling
activation blocks myomiR maturation depends on the inhibition
of KSRP function. UV-crosslinking/immunoprecipitation and
ribonucleoprotein immunoprecipitation (RIP) experiments re-
vealed that myogenic induction strongly enhanced the binding
activity of KSRP to pri-miR-206 and pri-miR-133b, whereas the
interaction was severely impaired by BMP2 treatment (Figures
3B, 3C, and S3F). As expected based on our previous data,
KSRP was unable to interact with pri-miR-23b in C2C12 cells
under all tested experimental conditions (Figure S3F, lower
panel; Trabucchi et al., 2009b). RIP experiments showed that
a transfected KSRP mutant unable to undergo AKT phosphory-
lation (S193A; Gherzi et al., 2006; Dı´az-Moreno et al., 2009;
Briata et al., 2012) was unable to interact with pri-miR-206
upon AKT signaling activation induced by expression of a consti-
tutively active form of AKT1 (myrAKT1; Gherzi et al., 2006;
Figures S3G and S3H). Accordingly, a transfected phosphomi-
metic KSRP mutant (S193D; Dı´az-Moreno et al., 2009) was
able to interact with pri-miR-206 in the absence of AKT activation
(Figures S3G and S3H). Consistently, RNA/GST pull-down
experiments performed using total-cell extracts from C2C121162 Cell Reports 2, 1159–1168, November 29, 2012 ª2012 The Autcells cultured in DM revealed that a mutation in the AKT phos-
phorylation site (S193A) abrogated KSRP ability to interact with
endogenous pri-miR-206 (Figure 3D).
In vitro pri-miRNA-processing assays confirmed that BMP2
treatment compromises the ability of cell extracts to process
pri-miR-206. The processing activity was restored by the addi-
tion of an excess of purified recombinant KSRP to the reaction
mixtures (Figure 3E).
Notably, BMP2 treatment did not affect either KSRP expres-
sion levels or its cellular localization or its phosphorylation
(Figures S3I and 3F). Altogether, these results suggest that the
functional interaction between AKT-phosphorylated KSRP and
other regulatory proteins belonging to the BMP/SMAD signaling
pathway might account for the blockade of myomiR maturation
required for osteoblastic differentiation of C2C12 cells.
KSRP/SMAD Interaction Prevents myomiR Maturation
and Orients C2C12 Cell Differentiation
We observed that phosphorylation of R-SMADs occurs early
upon BMP2 treatment of C2C12 cells and is rapidly followed
by inhibition of primary myomiR maturation (Figures S4A and
S4B; data not shown). R-SMADs have been reported to bind
to the R-SMAD-binding element (R-SBE, either CAGAC or
CAGGG) in a group of pri-miRNAs in response to TGF-b/BMP
signaling activation in pulmonary smooth muscle cells (Davis
et al., 2008, 2010), and we confirmed that this was indeed the
case also in C2C12 cells cultured in DM plus BMP2 (examples
are provided in Figure S4C, left panels). On the contrary, we
could not find any R-SMAD/primary myomiR interactions in
C2C12 cells as expected on the basis of the absence of the
R-SBE in the 300 nucleotides flanking the mature myomiRs (Fig-
ure S4C, right panels).
Strikingly, we found that phosphorylated R-SMADs interact
with KSRP in C2C12 cells cultured in DM plus BMP2 as revealedhors
by both coimmunoprecipitation and GST pull-down experiments
(Figures 4A and 4B). This interaction was RNase A insensitive
and was abrogated by the S193A mutation (Figures 4B and
S4D). Furthermore, a transfected SMAD5 lacking the C-terminal
phosphorylation sites (phmSMAD5), differently from its wild-type
counterpart, was unable to interact with KSRP (Figure 4C). It is
known that, in response to BMP2, phosphorylated R-SMADs
associate with SMAD4 and translocate into the nucleus (Miya-
zono et al., 2010). Indeed, data presented in Figure 4D indicate
that KSRP was part of a complex including also SMAD4 in
BMP2-treated cells. Among the four KH domains that enable
KSRP to interact with RNA targets as well as other proteins,
the third and fourth, which account for the majority of pri-miR-
206-binding activity (R.G. and P.B., unpublished data), are
predominant in the KSRP/R-SMAD interaction (Figure 4E).
Altogether, these findings allowed us to hypothesize that the
interaction with SMADs could hinder the ability of KSRP to
interact with primary myomiRs. RIP experiments performed in
BMP2-treated C2C12 cells revealed that silencing of SMAD4,
SMAD5, and SMAD9 (Figures S5A and S5B) was able to restore
KSRP binding to primary myomiRs (Figure 5A), whereas it failed
to affect KSRP interaction with unstable mRNAs (i.e., Bmpr2
transcript in Figure S5C; data not shown). To rule out possible
indirect consequences of SMAD silencing and to prove the direct
effect of a protein complex including SMADs on KSRP function,
we performed in-vitro-binding experiments using proteins puri-
fied by immunoprecipitation from C2C12 cell extracts. As shown
in Figure 5B, preincubation with SMADs immunopurified from
C2C12 cells cultured in DM plus BMP2, but not with SMADs
immunopurified from C2C12 cultured in DM, impaired the ability
of immunopurified phosphorylated KSRP to associate with in-
vitro-synthesized pri-miR-206. This indicated that a complex
including phosphorylated R-SMADs was able to directly inhibit
phosphorylated KSRP binding to pri-miR-206. In keeping with
results described in this paragraph, SMAD silencing in C2C12
cells cultured in DMplus BMP2 relieved the blockade of myomiR
maturation from their primary transcripts (Figure 5C), signifi-
cantly enhanced the expression of myogenic markers, and
reduced the expression of osteoblastic markers (Figures 5D,
S5D, and S5E).
In conclusion, uponDMplus BMP2 treatment, phosphorylated
KSRP associates to a complex including phosphorylated R-
SMADs and SMAD4, and this impairs its ability to interact with
primary myomiRs and to promote their processing. This mecha-
nism contributes to the osteoblast differentiation of C2C12 cells.
DISCUSSION
We have identified an unanticipated BMP/SMAD-dependent
inhibition of KSRP’s ability to promote maturation of myomiRs
from their primary transcripts. This event is required to orient
mesenchymal C2C12 cells toward osteoblast differentiation
(Figure S6).
KSRP silencing in C2C12 cells causes a reshaping of the tran-
scriptome, largely overlapping that produced by BMP/SMAD
signaling activation. myomiRs have been implicated, with oppo-
site outcomes, in bothmyogenic and osteoblastic differentiation,
and we made the striking observation that miR-206 re-expres-Cell Resion in KSRP-silenced cells is sufficient to enhance myogenin
expression and to abrogate the osteoblastic phenotype. Thus,
we propose that the most critical consequence of KSRP
silencing is the impairment of myomiR maturation and that this
is sufficient to determine C2C12 cell fate.
Our observations indicate that miR-206 and miR-133b have
a functional role also in undifferentiated C2C12 cells because
KSRP silencing-mediated inhibition of their expression induces
osteoblast differentiation markers in cells cultured in GM. This
underscores the relevance of maintaining a basal KSRP-medi-
ated myomiR-processing activity to keep C2C12 cells poised
to respond to myogenic stimuli. Instead, upon BMP2 treatment,
KSRP-mediated myomiR maturation needs to be completely
abrogated.
We have previously shown that phosphorylation by AKT at
S193 enables KSRP to promote myomiR maturation upon
a myogenic stimulus (Briata et al., 2012). However, in C2C12
cells cultured in DMplus BMP2, KSRP, although phosphorylated
in S193, is unable to process primary myomiRs. Our data indi-
cate that the functional repression of phosphorylated KSRP
is a consequence of its interaction with a nuclear complex
including phosphorylated R-SMADs as well as SMAD4.
The previously described R-SBE (Davis et al., 2010) is absent
in primary myomiRs, and this is in keeping with the fact that we
could not find any SMAD/primary myomiR interactions. Interest-
ingly, although R-SBE-containing pri-miRNAs interacted with
R-SMADs also in C2C12 cells, their expression was not modu-
lated by culture in DM plus BMP2 (M.P., P.B., and R.G., unpub-
lished data), and this observation underscores the importance
of the cellular context in determining the final outcome of
TGF-b/BMP signaling activation. Here, we report a distinct and
unanticipated function for the SMAD complex that hinders the
interaction of KH domains 3 and 4 with primary myomiRs. Our
observations allow us to hypothesize the existence of at least
two different classes of miRNAs regulated by SMADs. Thematu-
ration of R-SBE-containing pri-miRNAs is positively controlled
by R-SMADs. Conversely, distinct pri-miRNAs, whose matura-
tion is favored by KSRP in C2C12 cells, do not directly interact
with SMADs, and their expression is negatively regulated
through protein-protein interactions.
The inhibition of KSRP function that we describe here is
different from the antagonism operated by either Lin28 or
hnRNPA1. When Lin28 is expressed in undifferentiated embry-
onic stem cells, it occludes the accessibility of pri-let-7 family
members to KSRP, whereas when Lin28 expression is abro-
gated, KSRP is allowed to promote maturation of let-7 family
precursors (Trabucchi et al., 2009b). In different cells, hnRNPA1
directly competes with KSRP for binding to pri-let-7a (Michlew-
ski and Ca´ceres, 2010). Notably, both Lin28 and hnRNPA1
directly interact with pri-miRNAs, whereas the inhibition oper-
ated by SMADs is RNA-binding independent. Neither hnRNPA1
nor Lin28A/B silencing affects C2C12 cell fate (P.B. and R.G.,
unpublished data), and these observations reinforce the notion
that distinct cellular milieux play an essential role in governing
the dynamic assembly of ribonucleoprotein complexes. In
a sense, KSRP appears to exert a ‘‘default’’-positive maturation
function on select pri-miRNAs with cell- and pathway-specific
negative modulators restricting its role.ports 2, 1159–1168, November 29, 2012 ª2012 The Authors 1163
Figure 3. BMP/SMAD Signaling Impairs KSRP Ability to Promote Primary myomiR Maturation
(A) qRT-PCR analysis of miR-206, miR-133b, andmiR-23b (upper panels) and their respective primary transcripts (lower panels) in either mock or shKSRPC2C12
cells cultured in either GM, DM, or DM plus BMP2.
(B) Total extracts from C2C12 cells cultured in GM, DM, or DM plus BMP2 were UV crosslinked to in-vitro-synthesized 32P-labeled pri-miR-206 and subject to
immunoprecipitation using KSRP antibody. Immunocomplexes were analyzed by SDS-PAGE and autoradiographed. A representative autoradiogram is shown.
(C) C2C12 cells were cultured in GM, DM, or DM plus BMP2. Total-cell extracts were immunoprecipitated (IP) as indicated. RNA was purified from
immunocomplexes and analyzed by qRT-PCR to detect pri-miR-206.
1164 Cell Reports 2, 1159–1168, November 29, 2012 ª2012 The Authors
Figure 4. KSRP Interacts with SMAD
Proteins upon BMP Signaling Activation
(A) Coimmunoprecipitation of SMAD5 and SMAD9
and KSRP in total extracts from C2C12 cells
cultured in DM plus BMP2. Cell lysates were
immunoprecipitated as indicated and analyzed by
immunoblotting using monoclonal KSRP antibody
(top panel). Inputs were probed also with either
anti-SMAD5, anti-SMAD9 or anti-phospho-
SMAD5, anti-phospho-SMAD9 (p-SMAD5, p-
SMAD9).
(B) GST pull-down of endogenous SMAD5 and
SMAD9 from total extracts of C2C12 cells cultured
in DM plus 300 ng/ml BMP for 24 hr using either
control GST, GST-KSRP or GST-KSRP(S193A) as
indicated. Cell extracts were preincubated with
either RNase A dissolved in water (15 mg/ml, +) or
with water ().
(C) Coimmunoprecipitation of either Flag-tagged
SMAD5 or Flag-tagged four amino acid C-terminal
deletion mutant of SMAD5 (phmSMAD5) with
endogenous KSRP in total-cell extracts from
HEK293 transiently transfected with either a
plasmid expressing a constitutively active form of
AKT1 (myrAKT1) or the empty vector and treated
with BMP2.
(D) GST pull-down of endogenous KSRP from total
extracts of C2C12 cells cultured in GM, DM, or DM
plus BMP2 using either control GST or GST-
SMAD4.Proteinswereanalyzedby immunoblotting.
(E) GST pull-down of endogenous SMAD5 and
SMAD9 from total extracts of C2C12 cells cultured
in DM plus 300 ng/ml BMP for 24 hr using either
control GST, GST-KSRP or two KSRP deletion
mutants fusedwithGST (GST-KH12comprises the
first two KH domains, whereas GST-KH34
comprises the third and fourth KH domains).
Proteins were analyzed by immunoblotting.
Asterisks mark nonspecific immunoreactivity.
The position of molecular mass markers is indi-
cated on the left of each gel. Representative gels
are shown for each experiment.
See also Figure S4.TGF-b/BMP signaling is involved in the vast majority of cellular
processes and is fundamental during the entire life of metazoans
with its deregulation leading to developmental defects and/or
diseases, including cancer (Massague´, 2008; Ikushima and
Miyazono, 2010). Taking into account that members of the
TGF-b superfamily are known to exert a myriad of influences
on oncogenesis, implications of SMADs in the pleiotropic(D) RNA/GST pull-down performed using the indicated GST fusion proteins. Pro
protease and phosphatase inhibitors) prepared fromC2C12 cells cultured for 24 h
protein pellets were extensively washed; protein-bound RNA was extracted and
(E) In vitro pri-miR-206-processing assays performed using total extracts from C2
with either BSA (lanes 1–12) or purified recombinant KSRP (300 nM, lanes 13–16).
monitored as described in Experimental Procedures. A representative autoradio
(F) Immunoblot analysis of either nuclear (Nuc) or cytoplasmic (Cyto) extracts (20
directed toward the indicated protein (pKSRP is S193-phosphorylated KSRP). T
gels are displayed.
The values of qRT-PCR experiments shown are averages (±SEM) of three indep
**p < 0.001 (Student’s t test).
See also Figure S3.
Cell Reaspects of posttranscriptional control of gene expression pave
the way toward the discovery of novel targets of intervention.EXPERIMENTAL PROCEDURES
Cell cultures and transfections, antibodies, qRT-PCR, and pri-miRNA in-vitro-
processing assays are described in Extended Experimental Procedures.teins were incubated for 16 hr at 4C with total extracts (supplemented with
r in either DMor DMplus 300 ng/ml BMP2. Glutathione-sepharose-boundGST-
analyzed by qRT-PCR.
C12 cells cultured in GM, DM, or DM plus BMP2 and preincubated (1 hr at 4C)
Internally 32P-labeled pri-miR-206 RNA substrate was added and its processing
gram is shown.
mg) from C2C12 cells cultured in GM, DM, or DM plus BMP2 using antibodies
he position of molecular mass markers is indicated on the left. Representative
endent experiments performed in triplicate. Statistical significance: *p < 0.01,
ports 2, 1159–1168, November 29, 2012 ª2012 The Authors 1165
Figure 5. SMAD Protein Silencing Restores
KSRP Ability to Promote myomiR Matura-
tion Favoring Myogenic Differentiation of
C2C12 Cells
(A) C2C12 cells were transfected with either
control siRNA or siRNAs to SMAD4, SMAD5, and
SMAD9 and then cultured in DMplus BMP2. Total-
cell extracts were immunoprecipitated as indi-
cated. RNA was purified from immunocomplexes
and analyzed by qRT-PCR to detect either pri-
miR-206 or pri-miR-133b.
(B) Phosphorylated KSRP ((P)KSRP) immuno-
purified from C2C12 cultured in DM was pre-
incubated (for 4 hr at 4C) with SMAD proteins
immunopurified from C2C12 cells cultured either
in DM (SMAD) or in DM plus BMP2 ((P)SMAD).
Immunopurified proteins were incubated (1 hr at
4C) with in-vitro-synthesized pri-miR-206 in the
presence of heparin and yeast tRNA to inhibit
nonspecific binding. Upon extensive washes of
the pellets, RNA was extracted, and protein-
bound pri-miR-206 was quantitated by qRT-PCR.
The interaction observed in the absence of KSRP
corresponds to background binding activity.
(C) C2C12 cells were transfected with either
control siRNA or siRNAs to SMAD4, SMAD5, and
SMAD9 (as indicated) and then cultured in DM
plus 300 ng/ml BMP for 24 hr. RNA was prepared
and analyzed by qRT-PCR to quantitate the
expression of either mature miR-206 and miR-133
(upper panels) or the corresponding primary
transcripts (lower panels).
(D) C2C12 cells were transfected with either
control siRNA or siRNAs to SMAD4, SMAD5, and
SMAD9 and then cultured in DM plus BMP2. RNA
was prepared and analyzed by qRT-PCR in order
to quantitate the expression of either myogenin or
muscle creatine kinase (Ckm).
The values of qRT-PCR experiments shown are
averages (±SEM) of three independent experi-
ments performed in triplicate for each panel.
Statistical significance: *p < 0.005, **p < 0.001
(Student’s t test).
See also Figure S5.RNA-Seq Library Construction and Deep Sequencing
The RNA-seq library was generated from total RNA prepared using
miRNeasy (QIAGEN) and purified twice with Sera-mag Magnetic Oligo(dT)
Beads (Thermo Fisher) according to Illumina’s sample preparation instruction
at LC-Sciences. Further details are provided in Extended Experimental
Procedures.
Data Analysis and Bioinformatic Procedures
Procedures to analyze RNA-seq data sets are detailed in Extended Experi-
mental Procedures. In order to detect the presence of the sequences CAGAC
or CAGGG (binding sites for R-SMAD proteins described in Davis et al., 2010),
we utilized the ‘‘Fuzznuc’’ tool in the EMBOSS package (Rice et al., 2000).
Plasmids, Recombinant Proteins, and Antibodies
The construction of both pCDNA-based and pGEX-based plasmids containing
wild-type KSRP, KSRP(S193A), KH12, and KH14 mutants has been described
elsewhere (Gherzi et al., 2006). To generate pCDNA-based and pGEX-
based KSRP(S193D) mutant, we utilized the QuikChange Site-Directed
Mutagenesis Kit (Agilent Technologies). To generate pCDNA-based and
pGEX-based SMAD4 and SMAD5, specific cDNAs were obtained by PCR.1166 Cell Reports 2, 1159–1168, November 29, 2012 ª2012 The AutTo generate pCDNA-based and pGEX-based phmSMAD5 mutant, we cloned
a PCR fragment encompassing a human SMAD5 cDNA fragment lacking
the codons encoding the four C-terminal amino acids (SSVS). All plasmids
were sequenced prior to their utilization. Baculovirus-based production
and purification of His-tagged human KSRP were previously described (Briata
et al., 2005).
siRNA and shRNA-Mediated Knockdown
siRNAs utilized to knock down KSRP expression were described previously
by Trabucchi et al. (2009b). In order to knock down the expression of
SMAD4, SMAD5, or SMAD9, we utilized siRNAs purchased from Santa Cruz
Biotechnology.
RNA In Vitro Degradation
32P-labeled RNAs were synthesized and used as substrates for in-vitro-
degradation assays as reported (Briata et al., 2005).
RIP Complex Assays
RIP assays were performed as previously described (Briata et al., 2012)
with some modification. Briefly, cell lysates were immunoprecipitated withhors
Dynabeads (Invitrogen, Carlsbad, CA, USA) coated with protein A/protein
G and precoupled to specific antibodies at 4C overnight. Pellets were
washed four times with a buffer containing 50 mM Tris-HCl (pH 8.0),
150 mM NaCl, 0.5% Triton X-100, and 13 cOmplete (Roche). Total RNA
was prepared from immunocomplexes using the miRNeasy Mini Kit (QIAGEN),
retro-transcribed, and amplified by qPCR as described above. The primer
sequences are detailed in Extended Experimental Procedures.
Nuclear and Cytoplasmic Extract Preparation
Nuclear and cytoplasmic (S100) extracts were prepared as previously
described (Briata et al., 2005) in the presence of protease and phosphatase
inhibitors.
RNA/GST Pull-Down Assays
Beads were incubated (16 hr, 4C, rotating) with total-cell extracts supple-
mented with protease, phosphatase, and RNase inhibitors. After extensive
washes in PDB supplemented with protease, phosphatase, and RNase
inhibitors, RNA was extracted from beads and analyzed by qRT-PCR for
pri-miRNA quantitation.
UV Crosslinking followed by Immunoprecipitation
Total-cell extracts were prepared in the presence of protein phosphatase
inhibitors (PhosSTOP Phosphatase Inhibitor Cocktail; Roche, Mannheim,
DE, USA) (200 mg protein), and 32P-labeled RNA (5.0 ng = 2 3 106 cpm)
was incubated at 20C for 20 min in a RNA-binding buffer (200 ml) contain-
ing 10 mM HEPES (pH 7.6), 3 mM MgCl2, 100 mM KCl, 2 mM DTT, 5%
glycerol, 0.5% NP-40, yeast RNA (10 mg), and heparin (10 mg). Reaction
mixtures were transferred to a 24-well plate and irradiated at 4C for
10 min with a UV Stratalinker (Stratagene) at a distance of 5 cm. After
subsequent digestion with RNase A (2 mg per reaction) for 10 min at
37C, samples were subjected to immunoprecipitation overnight at 4C,
separated by SDS-PAGE, and 32P-labeled proteins were visualized by
autoradiography.
AP Staining
AP staining was performed using a commercial kit from Sigma-Aldrich (St.
Louis) according to manufacturer’s instructions.
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